Premiplex (mecasermin rinfabate) - Oak Hill Bio, Chiesi
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants (clinicaltrials.gov) - Aug 4, 2026 - P2 | N=295 | Active, not recruiting | Sponsor: OHB Neonatology Ltd. | Recruiting ➔ Active, not recruiting 
Enrollment closed • Bronchopulmonary Dysplasia • Hematological Disorders • Pulmonary Disease • Respiratory Diseases • Retinal Disorders • Retinopathy of Prematurity
http://clinicaltrials.gov/ct2/show/NCT03253263
 
Aug 4, 2026
 
Prev Next